Beyond protein binding: recent advances in screening DNA-encoded libraries.
Thomas KodadekNicholas G PaciaroniMadeline BalzariniPaige DicksonPublished in: Chemical communications (Cambridge, England) (2019)
DNA-encoded library (DEL) screening has emerged as an important method for early stage drug and probe molecule discovery. The vast majority of screens using DELs have been relatively simple binding assays. The library is incubated with a target molecule, which is almost always a protein, and the DNAs that remain associated with the target after thorough washing are amplified and deep sequenced to reveal the chemical structures of the ligands they encode. Recently however, a number of different screening formats have been introduced that demand more than simple binding. These include a format that demands hits exhibit high selectivity for target vs. off-targets, a protocol to screen for enzyme inhibitors and another to identify organocatalysts in a DEL. These and other novel assay formats are reviewed in this article. We also consider some of the most significant remaining challenges in DEL assay development.
Keyphrases
- sentinel lymph node
- early stage
- high throughput
- binding protein
- circulating tumor
- single cell
- cell free
- genome wide
- randomized controlled trial
- dna binding
- single molecule
- small molecule
- protein protein
- amino acid
- gene expression
- squamous cell carcinoma
- emergency department
- quantum dots
- dna methylation
- living cells
- transcription factor
- adverse drug
- mass spectrometry
- circulating tumor cells